I see expectation of revenue growth in 2016 but not much hint at the bottom line outcome? I'll be dissappointed if any further capital raisings are required but to avoid that it's going to need to get its bottom line improving
- Forums
- ASX - By Stock
- UCM
- Ann: Preliminary and Annual Report to shareholders
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.6¢

Ann: Preliminary and Annual Report to shareholders, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.007M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $1.573K | 98.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74999 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74999 | 0.016 |
1 | 300000 | 0.013 |
1 | 132270 | 0.012 |
1 | 46000 | 0.011 |
3 | 1100000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 200000 | 1 |
0.019 | 46000 | 1 |
0.021 | 24866 | 1 |
0.055 | 10083 | 1 |
0.100 | 57758 | 1 |
Last trade - 15.26pm 04/07/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online